What amount sold does SHOULDER INNOVATIONS, INC. report in Form D filings?

The latest linked filings report $79.6M sold across 5 identified offering(s). 1 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was SHOULDER INNOVATIONS, INC.'s most recent SEC filing?

SHOULDER INNOVATIONS, INC.'s most recent Form D filing was on 2025-03-18.

How many investors does SHOULDER INNOVATIONS, INC. have?

The most recent Form D filing lists 27 investor(s).

What type of securities does SHOULDER INNOVATIONS, INC. offer?

SHOULDER INNOVATIONS, INC.'s SEC Form D filings indicate equity offerings.

SHOULDER INNOVATIONS, INC.

CIK: 0001699350·Other Health Care·Grand Rapids, MI·Corporation

Reported Sold

$79,610,088

Total Filings

Identified Offerings

Last Filed

Mar 18, 2025

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately. 1 unlinked amendment excluded.

About

Company in Other Health Care industry

SEC EDGAR

Offering filing timeline

Mar 18, 2025Form D — New notice

Reported sold: $20,111,432 · Target: $40,129,987

Rule 506(b)·27 investors

Feb 22, 2023Form D — New notice

Reported sold: $32,229,523 · Target: $39,821,690

Rule 506(b)·21 investors

Oct 6, 2022Form D — New notice

Reported sold: $3,519,131 · Target: $7,000,000

Rule 506(b)·5 investors

Oct 29, 2020Form D — New notice

Reported sold: $21,550,002 · Target: $21,550,002

Rule 506(b)·24 investors

Feb 3, 2020Form D — New notice

Reported sold: $2,200,000 · Target: $2,200,000

Rule 506(b)·31 investors

Nov 1, 2018Form D/A — Amendment

Reported sold: $5,117,451 · Target: $5,600,000

No verified predecessor available.

Rule 506(b)·27 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

17%

Latest reported sold across 5 identified offerings

$79,610,088

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

1 unlinked amendment excluded.

Key People

Robert Ball

Related Person

Appears on 4 filings

Matthew Ahearn

Related Person

Appears on 4 filings

David Blue

Related Person

Appears on 4 filings

Casey Tansey

Related Person

Appears on 4 filings

Mike Carusi

Related Person

Appears on 4 filings

Kevin Sidow

Related Person

Appears on 4 filings

Paul Buckman

Related Person

Appears on 4 filings

Geoff Pardo

Related Person

Appears on 2 filings

Filing History

Date	Type	Offering target	Reported sold	Investors
Mar 18, 2025	New	$40,129,987	$20,111,432	27
Feb 22, 2023	New	$39,821,690	$32,229,523	21
Oct 6, 2022	New	$7,000,000	$3,519,131	5
Oct 29, 2020	New	$21,550,002	$21,550,002	24
Feb 3, 2020	New	$2,200,000	$2,200,000	31
Nov 1, 2018	Amendment	$5,600,000	$5,117,451	27

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Salus Scientific Corp.

Other Health Care

Offering target: $30,000,000

Filed Oct 22, 2026